ArticleInternational journal of toxicology

Preclinical Safety Assessment and Toxicokinetics of Apitegromab, an Antibody Targeting Proforms of Myostatin for the Treatment of Muscle-Atrophying Disease.

Brian T Welsh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.